{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:34:23Z","timestamp":1794270863295,"version":"4.9.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T00:00:00Z","timestamp":1657929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T00:00:00Z","timestamp":1657929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"AIIMS, Rishikesh","award":["319\/IEC\/Ph.D.\/2018"],"award-info":[{"award-number":["319\/IEC\/Ph.D.\/2018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Pseudomonas aeruginosa<\/jats:italic> is an adaptable bacterial pathogen that infects a variety of organs, including the respiratory tract, vascular system, urinary tract, and central nervous system, causing significant morbidity and mortality. As the primary goal of this study, we wanted to determine how pigment color production differed between clinical strains of <jats:italic>P. aeruginosa<\/jats:italic>, and whether or not that variation was associated with multidrug resistance or the ability to form biofilms. We screened in total 30.1% of yellow, 39.8% green and 30.1% of no pigment-producing <jats:italic>P. aeruginosa<\/jats:italic> strains from a total of 143 various clinical isolates. Yellow pigment-producing strains presented significant resistance to antibiotics groups, including \u03b2-lactam (91.5%), aminoglycosides (70.5%), and carbapenems (51.9%) compared to green and non-pigmented strains. Notably, 16.3% of yellow pigment-producing strains were resistant to colistin which is used as a last-resort treatment for multidrug-resistant bacteria, whereas only 2.3% of non-pigmented and 1.8% of green pigmented strains were resistant to colistin. Aside from that, yellow pigment-producing strains were frequent producers of enzymes belonging to the lactamase family, including ESBL (55.6%), MBL (55.6%), and AmpC (50%). Compared to the green groups (7.14%) and non-pigmented groups (28.5%), they had a higher frequency of efflux positive groups (64.2%). Notably, when compared to non-pigmented groups, green pigment-producing strains also displayed antibiotic susceptibility behavior similar to yellow pigment-producing strains. The majority of yellow pigment-producing strains outperformed the green and non-pigmented strains in terms of MIC levels when compared to the other two groups of strains. Despite the fact that previous studies have demonstrated a direct correlation between multidrug resistance behaviors and biofilm production, no such statistically significant association between pigment and biofilm formation was found in our investigation. Our research has demonstrated that the correlation of bacterial pigments on their susceptibility to antimicrobial agents. Yellow pigment-producing <jats:italic>P. aeruginosa<\/jats:italic> strains posed a significant problem due to the lack of alternative agents against such transformed strains, which may be associated with the development of multidrug resistance.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s40001-022-00752-6","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T07:03:46Z","timestamp":1657955026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Association of multidrug resistance behavior of clinical Pseudomonas aeruginosa to pigment coloration"],"prefix":"10.1186","volume":"27","author":[{"given":"Ashish","family":"Kothari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam Kishor","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karanvir","family":"Kaushal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balram Ji","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,16]]},"reference":[{"key":"752_CR1","doi-asserted-by":"publisher","first-page":"774","DOI":"10.12688\/f1000research.24818.3","volume":"9","author":"DN Abdelrahman","year":"2020","unstructured":"Abdelrahman DN, Taha AA, Dafaallah MM, Mohammed AA, El Hussein ARM, Hashim AI, Hamedelnil YF, Altayb HN. beta-lactamases (bla TEM, bla SHV, bla CTXM-1, bla VEB, bla OXA-1) and class C beta-lactamases gene frequency in Pseudomonas aeruginosa isolated from various clinical specimens in Khartoum State, Sudan: a cross sectional study. F1000Res. 2020;9:774.","journal-title":"F1000Res"},{"issue":"2","key":"752_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.idcr.2015.01.004","volume":"2","author":"MJ Gale","year":"2015","unstructured":"Gale MJ, Maritato MS, Chen YL, Abdulateef SS, Ruiz JE. Pseudomonas aeruginosa causing inflammatory mass of the nasopharynx in an immunocompromised HIV infected patient: a mimic of malignancy. IDCases. 2015;2(2):40\u20133.","journal-title":"IDCases"},{"issue":"1","key":"752_CR3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s12879-018-3413-1","volume":"18","author":"A Gomila","year":"2018","unstructured":"Gomila A, Carratala J, Badia JM, Camprubi D, Piriz M, Shaw E, Diaz-Brito V, Espejo E, Nicolas C, Brugues M, et al. Preoperative oral antibiotic prophylaxis reduces Pseudomonas aeruginosa surgical site infections after elective colorectal surgery: a multicenter prospective cohort study. BMC Infect Dis. 2018;18(1):507.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"752_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","volume":"37","author":"Z Pang","year":"2019","unstructured":"Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv. 2019;37(1):177\u201392.","journal-title":"Biotechnol Adv"},{"issue":"1","key":"752_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/emph\/eoaa033","volume":"2020","author":"E Gjini","year":"2020","unstructured":"Gjini E, Pauperio FFS, Ganusov VV. Treatment timing shifts the benefits of short and long antibiotic treatment over infection. Evol Med Public Health. 2020;2020(1):249\u201363.","journal-title":"Evol Med Public Health"},{"key":"752_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fmicb.2011.00065","volume":"2","author":"K Poole","year":"2011","unstructured":"Poole K. Pseudomonas aeruginosa: resistance to the max. Front Microbiol. 2011;2:65.","journal-title":"Front Microbiol"},{"issue":"8","key":"752_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.tim.2011.04.005","volume":"19","author":"EB Breidenstein","year":"2011","unstructured":"Breidenstein EB, de la Fuente-Nunez C, Hancock RE. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 2011;19(8):419\u201326.","journal-title":"Trends Microbiol"},{"key":"752_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.drup.2015.08.002","volume":"21\u201322","author":"A Oliver","year":"2015","unstructured":"Oliver A, Mulet X, Lopez-Causape C, Juan C. The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist Updat. 2015;21\u201322:41\u201359.","journal-title":"Drug Resist Updat"},{"key":"752_CR9","unstructured":"Krieg NR: Bergey\u2019s manual of systematic bacteriology. In., 2nd edn.: Springer-Verlag; 2010."},{"key":"752_CR10","unstructured":"Prince AS: Principles and practice of pediatric infectious diseases. In., Forth edn.; 2012."},{"issue":"5","key":"752_CR11","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/j.1365-2958.2006.05306.x","volume":"61","author":"LE Dietrich","year":"2006","unstructured":"Dietrich LE, Price-Whelan A, Petersen A, Whiteley M, Newman DK. The phenazine pyocyanin is a terminal signalling factor in the quorum sensing network of Pseudomonas aeruginosa. Mol Microbiol. 2006;61(5):1308\u201321.","journal-title":"Mol Microbiol"},{"issue":"1","key":"752_CR12","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.sjbs.2020.11.031","volume":"28","author":"RM Elbargisy","year":"2021","unstructured":"Elbargisy RM. Optimization of nutritional and environmental conditions for pyocyanin production by urine isolates of Pseudomonas aeruginosa. Saudi J Biol Sci. 2021;28(1):993\u20131000.","journal-title":"Saudi J Biol Sci"},{"issue":"3","key":"752_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00284-014-0593-9","volume":"69","author":"LM Ketelboeter","year":"2014","unstructured":"Ketelboeter LM, Potharla VY, Bardy SL. NTBC treatment of the pyomelanogenic Pseudomonas aeruginosa clinical isolate PA1111 inhibits pigment production and increases sensitivity to oxidative stress. Curr Microbiol. 2014;69(3):343\u20138.","journal-title":"Curr Microbiol"},{"key":"752_CR14","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3389\/fmicb.2019.02048","volume":"10","author":"D Kang","year":"2019","unstructured":"Kang D, Revtovich AV, Chen Q, Shah KN, Cannon CL, Kirienko NV. Pyoverdine-dependent virulence of Pseudomonas aeruginosa isolates from cystic fibrosis patients. Front Microbiol. 2019;10:2048.","journal-title":"Front Microbiol"},{"issue":"1","key":"752_CR15","first-page":"24","volume":"60","author":"EA Finlayson","year":"2011","unstructured":"Finlayson EA, Brown PD. Comparison of antibiotic resistance and virulence factors in pigmented and non-pigmented Pseudomonas aeruginosa. West Indian Med J. 2011;60(1):24\u201332.","journal-title":"West Indian Med J"},{"issue":"2","key":"752_CR16","first-page":"155","volume":"58","author":"A Peymani","year":"2017","unstructured":"Peymani A, Naserpour-Farivar T, Zare E, Azarhoosh KH. Distribution of blaTEM, blaSHV, and blaCTX-M genes among ESBL-producing P. aeruginosa isolated from Qazvin and tehran hospitals. Iran J Prev Med Hyg. 2017;58(2):155\u201360.","journal-title":"Iran. J Prev Med Hyg."},{"issue":"3","key":"752_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4103\/0974-777X.68531","volume":"2","author":"D Rawat","year":"2010","unstructured":"Rawat D, Nair D. Extended-spectrum beta-lactamases in gram negative bacteria. J Glob Infect Dis. 2010;2(3):263\u201374.","journal-title":"J Glob Infect Dis"},{"issue":"1","key":"752_CR18","first-page":"70","volume":"7","author":"L Oberoi","year":"2013","unstructured":"Oberoi L, Singh N, Sharma P, Aggarwal A. ESBL, MBL and ampc beta lactamases producing superbugs - havoc in the intensive care units of Punjab India. J Clin Diagn Res. 2013;7(1):70\u20133.","journal-title":"J Clin Diagn Res"},{"key":"752_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ebiom.2019.02.061","volume":"41","author":"O Cunrath","year":"2019","unstructured":"Cunrath O, Meinel DM, Maturana P, Fanous J, Buyck JM, Saint Auguste P, Seth-Smith HMB, Korner J, Dehio C, Trebosc V, et al. Quantitative contribution of efflux to multi-drug resistance of clinical Escherichia coli and Pseudomonas aeruginosa strains. EBioMedicine. 2019;41:479\u201387.","journal-title":"EBioMedicine"},{"key":"752_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fcimb.2017.00039","volume":"7","author":"MF Moradali","year":"2017","unstructured":"Moradali MF, Ghods S, Rehm BH. Pseudomonas aeruginosa lifestyle: a paradigm for adaptation, survival, and persistence. Front Cell Infect Microbiol. 2017;7:39.","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"752_CR21","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.15514","volume":"8","author":"S Heydari","year":"2015","unstructured":"Heydari S, Eftekhar F. Biofilm formation and beta-lactamase production in burn isolates of Pseudomonas aeruginosa. Jundishapur J Microbiol. 2015;8(3): e15514.","journal-title":"Jundishapur J Microbiol"},{"key":"752_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jgar.2018.01.018","volume":"13","author":"L Asadpour","year":"2018","unstructured":"Asadpour L. Antimicrobial resistance, biofilm-forming ability and virulence potential of Pseudomonas aeruginosa isolated from burn patients in northern Iran. J Glob Antimicrob Resist. 2018;13:214\u201320.","journal-title":"J Glob Antimicrob Resist"},{"issue":"12","key":"752_CR23","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3390\/antibiotics9120896","volume":"9","author":"N Szemeredi","year":"2020","unstructured":"Szemeredi N, Kincses A, Rehorova K, Hoang L, Salardon-Jimenez N, Sevilla-Hernandez C, Viktorova J, Dominguez-Alvarez E, Spengler G. Ketone- and Cyano-Selenoesters to overcome efflux pump, quorum-sensing, and biofilm-mediated resistance. Antibiotics. 2020;9(12):896.","journal-title":"Antibiotics"},{"issue":"3","key":"752_CR24","first-page":"231","volume":"71","author":"M Milojkovic","year":"2020","unstructured":"Milojkovic M, Nenadovic Z, Stankovic S, Bozic DD, Nedeljkovic NS, Cirkovic I, Petrovic M, Dimkic I. Phenotypic and genetic properties of susceptible and multidrug-resistant Pseudomonas aeruginosa isolates in Southern Serbia. Arh Hig Rada Toksikol. 2020;71(3):231\u201350.","journal-title":"Arh Hig Rada Toksikol"},{"issue":"6","key":"752_CR25","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/mmi.14132","volume":"110","author":"LA Meirelles","year":"2018","unstructured":"Meirelles LA, Newman DK. Both toxic and beneficial effects of pyocyanin contribute to the lifecycle of Pseudomonas aeruginosa. Mol Microbiol. 2018;110(6):995\u20131010.","journal-title":"Mol Microbiol"},{"key":"752_CR26","unstructured":"Collee JG DJ, Fraser AG, Marmion BP, Simmons A: Laboratory strategy in the diagnosis of infective syndromes. In. Volume 14, edn.: Mackie and McCartney practical medical microbiology; 1996: 53\u201394."},{"key":"752_CR27","unstructured":"Hudzicki J: Kirby-bauer disk diffusion susceptibility test In., edn.: ASM; 2009."},{"issue":"3","key":"752_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"752_CR29","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1128\/JCM.00977-15","volume":"53","author":"L Poirel","year":"2015","unstructured":"Poirel L, Nordmann P. Rapidec carba NP test for rapid detection of carbapenemase producers. J Clin Microbiol. 2015;53(9):3003\u20138.","journal-title":"J Clin Microbiol"},{"key":"752_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.586750","volume":"10","author":"J Tang","year":"2020","unstructured":"Tang J, Wang W, Chu W. Antimicrobial and anti-quorum sensing activities of phlorotannins from seaweed (Hizikia fusiforme). Front Cell Infect Microbiol. 2020;10: 586750.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"752_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3947\/ic.2015.47.2.81","volume":"47","author":"DJ Hong","year":"2015","unstructured":"Hong DJ, Bae IK, Jang IH, Jeong SH, Kang HK, Lee K. Epidemiology and characteristics of metallo-beta-lactamase-producing Pseudomonas aeruginosa. Infect Chemother. 2015;47(2):81\u201397.","journal-title":"Infect Chemother"},{"key":"752_CR32","doi-asserted-by":"publisher","first-page":"106160","DOI":"10.1016\/j.mimet.2021.106160","volume":"182","author":"N Jackson","year":"2021","unstructured":"Jackson N, Borges CA, Tarlton NJ, Resendez A, Milton AK, de Boer TR, Butcher CR, Murthy N, Riley LW. A rapid, antibiotic susceptibility test for multidrug-resistant, gram-negative bacterial uropathogens using the biochemical assay detect. J Microbiol Methods. 2021;182:106160.","journal-title":"J Microbiol Methods"},{"key":"752_CR33","doi-asserted-by":"crossref","unstructured":"Demord A, Poirel L, D'Emidio F, Pomponio S, Nordmann P. Rapid ESBL NP test for rapid detection of expanded-spectrum \u03b2-lactamase producers in Enterobacterales. Microbial Drug Resistance. 2021 Aug 1;27(8):1131-5.","DOI":"10.1089\/mdr.2020.0391"},{"issue":"4","key":"752_CR34","first-page":"303","volume":"9","author":"SM Rudresh","year":"2017","unstructured":"Rudresh SM, Ravi GS, Sunitha L, Hajira SN, Kalaiarasan E, Harish BN. Simple, rapid, and cost-effective modified carba np test for carbapenemase detection among gram-negative bacteria. J Lab Phys. 2017;9(4):303\u20137.","journal-title":"J Lab Phys"},{"key":"752_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-6-7","author":"S Begum","year":"2013","unstructured":"Begum S, Salam MA, Alam KF, Begum N, Hassan P, Haq JA. Detection of extended spectrum \u03b2-lactamase in Pseudomonas spp. isolated from two tertiary care hospitals in Bangladesh. BMC research notes. 2013 Dec;6(1):1-4.","journal-title":"BMC Res Notes"},{"key":"752_CR36","doi-asserted-by":"publisher","first-page":"6633888","DOI":"10.1155\/2021\/6633888","volume":"2021","author":"AA El Shamy","year":"2021","unstructured":"El Shamy AA, Zakaria Z, Tolba MM, Salah Eldin N, Rabea AT, Tawfick MM, Nasser HA. AmpC beta-lactamase variable expression in common multidrug-resistant nosocomial bacterial pathogens from a tertiary hospital in cairo, Egypt. Int J Microbiol. 2021;2021:6633888.","journal-title":"Int J Microbiol"},{"issue":"1","key":"752_CR37","doi-asserted-by":"publisher","first-page":"7110","DOI":"10.1038\/s41598-021-86570-y","volume":"11","author":"MC Hosu","year":"2021","unstructured":"Hosu MC, Vasaikar SD, Okuthe GE, Apalata T. Detection of extended spectrum beta-lactamase genes in Pseudomonas aeruginosa isolated from patients in rural eastern cape province, South Africa. Sci Rep. 2021;11(1):7110.","journal-title":"Sci Rep"},{"issue":"18","key":"752_CR38","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1016\/j.jmb.2019.04.002","volume":"431","author":"CL Tooke","year":"2019","unstructured":"Tooke CL, Hinchliffe P, Bragginton EC, Colenso CK, Hirvonen VHA, Takebayashi Y, Spencer J. beta-Lactamases and beta-Lactamase Inhibitors in the 21st Century. J Mol Biol. 2019;431(18):3472\u2013500.","journal-title":"J Mol Biol"},{"issue":"2","key":"752_CR39","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/jac\/dkg098","volume":"51","author":"V Manchanda","year":"2003","unstructured":"Manchanda V, Singh NP. Occurrence and detection of AmpC beta-lactamases among gram-negative clinical isolates using a modified three-dimensional test at guru tegh bahadur hospital, Delhi, India. J Antimicrob Chemother. 2003;51(2):415\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"752_CR40","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1007\/s11033-021-06262-8","volume":"48","author":"SM Liew","year":"2021","unstructured":"Liew SM, Puthucheary SD, Rajasekaram G, Chai HC, Chua KH. Proteomic profiling of clinical and environmental strains of Pseudomonas aeruginosa. Mol Biol Rep. 2021;48(3):2325\u201333.","journal-title":"Mol Biol Rep"},{"issue":"4","key":"752_CR41","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","volume":"18","author":"DL Paterson","year":"2005","unstructured":"Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657\u201386.","journal-title":"Clin Microbiol Rev"},{"key":"752_CR42","doi-asserted-by":"publisher","first-page":"104989","DOI":"10.1016\/j.micpath.2021.104989","volume":"157","author":"L Yamani","year":"2021","unstructured":"Yamani L, Alamri A, Alsultan A, Alfifi S, Ansari MA, Alnimr A. Inverse correlation between biofilm production efficiency and antimicrobial resistance in clinical isolates of Pseudomonas aeruginosa. Microb Pathog. 2021;157:104989.","journal-title":"Microb Pathog"},{"issue":"1","key":"752_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13104-020-4890-z","volume":"13","author":"E Kamali","year":"2020","unstructured":"Kamali E, Jamali A, Ardebili A, Ezadi F, Mohebbi A. Evaluation of antimicrobial resistance, biofilm forming potential, and the presence of biofilm-related genes among clinical isolates of Pseudomonas aeruginosa. BMC Res Notes. 2020;13(1):27.","journal-title":"BMC Res Notes"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-022-00752-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-022-00752-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-022-00752-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T07:14:43Z","timestamp":1657955683000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-022-00752-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,16]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["752"],"URL":"https:\/\/doi.org\/10.1186\/s40001-022-00752-6","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,16]]},"assertion":[{"value":"1 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the All Indian Institute of Medical Sciences Rishikesh, India (Ethical approval number ECR\/736\/Inst\/UK\/2015\/RR-18).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}